Search
for
Sort by
Research 721–750 of 1000+
- More than one way to skin . . .
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Bioengineering skin using mechanisms of regeneration and repair
- Volatile signalling by sesquiterpenes from ectomycorrhizal fungi reprogrammes root architecture
- The PDGF/PDGFR pathway as a drug target
- Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period
- A new look into an old problem: keratins as tools to investigate determination, morphogenesis, and differentiation in skin.
- Molecular biology of hair morphogenesis: Development and cycling
- Gender differences in skin: A review of the literature
- Lupus erythematosus: systemic and cutaneous manifestations
- Hormone replacement therapy and the skin
- Extraskeletal actions of vitamin D
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53
- Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
- Reproductive seasonality and maturation throughout the complete life-cycle in the mouflon ram (Ovis musimon)
- The roles of Wnt/β‐catenin pathway in tissue development and regenerative medicine
- Antioxidants in dermatology
- TGF-β Family Signaling in Epithelial Differentiation and Epithelial–Mesenchymal Transition
- Steroid Biomarkers and Genetic Studies Reveal Inactivating Mutations in Hexose-6-Phosphate Dehydrogenase in Patients with Cortisone Reductase Deficiency
- Safety of testosterone treatment in postmenopausal women
- Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Primary cicatricial alopecia
- EdnrB Governs Regenerative Response of Melanocyte Stem Cells by Crosstalk with Wnt Signaling
- Graft-versus-host disease
- Choreographing Immunity in the Skin Epithelial Barrier